Zimmer Biomet Holdings (ZBH) Debt to Equity (2009 - 2026)

Zimmer Biomet Holdings' Debt to Equity history runs 18 years deep, the most recent figure standing at $0.59 for Q1 2026.

• In Q1 2026, Debt to Equity rose 1.83% year-over-year to $0.59; the TTM figure through Mar 2026 stood at $0.59 (up 1.83% YoY), while the FY2025 annual figure was $0.59, up 19.0% from the prior year.
• Debt to Equity was $0.59 for Q1 2026 at Zimmer Biomet Holdings, roughly flat from $0.59 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.64 in Q3 2025 to a low of $0.44 in Q3 2023.
• Historically, Debt to Equity has averaged $0.51 across 5 years, with a median of $0.5 in 2022.
• The sharpest annual moves came in 2022 and 2025: Debt to Equity retreated 20.97% in 2022, then soared 32.01% in 2025.
• A 5-year view of Debt to Equity shows it stood at $0.47 in 2022, then decreased by 2.49% to $0.46 in 2023, then rose by 7.67% to $0.5 in 2024, then increased by 19.0% to $0.59 in 2025, then declined by 0.45% to $0.59 in 2026.
• The last three Debt to Equity figures came in at $0.59 (Q1 2026), $0.59 (Q4 2025), and $0.64 (Q3 2025), per Business Quant data.